ArticlePLoS pathogens2019

IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies.

Wenwen Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.